THURSDAY, July 6, 2023 (HealthDay News) -- Did you know the U.S. Centers for Disease Control and Prevention estimates that there were nearly 68,000 new cases of acute hepatitis C in 2020 and over ...

Hepatitis C is the leading cause of chronic liver disease and liver cancer in the world and affects an estimated 51 million people globally. Though the viral infection is easily diagnosable and ...

Thanks to medical breakthroughs, doctors can probably cure your hepatitis C. But if you don’t get treatment, it can lead to liver disease, liver cancer, or death. Despite this, there are fewer people ...

Hepatitis C infection. Computer illustration showing liver and close-up view of hepatitis C viruses. Studies show that mortality, morbidity, and hepatic decompensation risks increase with coinfection ...

This UCLA Health mobile clinic is part of a study that is assessing the effectiveness of a one-stop mobile unit to link people who inject drugs to health services, including treatment for hepatitis C.

Figure 1. The direct-acting antiviral targets in the hepatitis C virus replication cycle. NS3/4A protease inhibitors target the NS3/4A protease enzyme which is needed for the virus to develop the ...

Whether hepatitis resolves depends on the type and whether a person receives treatment. Hepatitis A usually resolves without medications, and while sometimes hepatitis B and C may last only a few ...

As the opioid epidemic has worsened in the United States, prevalence of hepatitis C has also increased. Hepatitis C is a bloodborne virus that damages the liver. It is mainly spread through sharing ...

People who inject drugs have historically struggled to get treatment for the virus. Here’s how one physician has helped fight the stigma. When Lynn Taylor, MD, was in medical school, she studied under ...

This article estimates the comprehensive value of direct-acting antivirals for the treatment of hepatitis C virus using a generalized cost-effectiveness analysis. Objectives: To estimate the ...

Fewer people have gotten crucial medication for hepatitis C under Medi-Cal in recent years, troubling advocates who have pushed to expand the lifesaving treatment. Hepatitis C, a slow-moving virus ...